We are thrilled to announce that Assistant Professor, Dr. Fan Zhang from the UF College of Pharmacy has been awarded pilot funding through the Sepsis & Critical Illness Research Center’s Biomedical Research Collective (BRC): Enhancing the Interdisciplinary Approach to Translational Scientific Inquiry- an RM1GM139690 Pilot Program.
Dr. Zhang’s innovative project, “Selective Reprogram of MDSCs through Nanomedicine-Mediated STAT3 Inhibition”holds immense promise in reshaping our understanding of MDSCs (Myeloid-Derived Suppressor Cells) and their role in immune regulation. Dr. Zhang’s research dives deep into understanding critical illnesses like sepsis, aiming to revolutionize treatment options through nanotechnology. The SCIRC’s recognition of Dr. Zhang’s work underscores its potential impact on patient care and outcomes. With his passion for pushing scientific boundaries, Zhang’s project holds immense promise for transforming the landscape of critical care medicine.
Congratulations, Dr. Fan Zhang, on this well-deserved achievement! We eagerly anticipate the positive impact your pilot program will have, and we are committed to supporting you throughout its implementation.
To learn more about Dr. Zhang’s research, please visit:https://pharmacy.ufl.edu/profile/zhang-fan-10/.